Allogeneic Stem Cell Transplantation

Since the original publication of Allogeneic Stem Cell Transplantation: Clinical Research and Practice, Allogeneic hematopoietic stem cell transplantation (HSC) has undergone several fast-paced changes. In this second edition, the editors have focused on topics relevant to evolving knowledge in the...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Lazarus, Hillard M. (Επιμελητής έκδοσης), Laughlin, Mary J. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Totowa, NJ : Humana Press, 2010.
Σειρά:Contemporary Hematology
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Allogeneic Stem Cell Transplantation: The Last Century
  • Full Intensity and Reduced Intensity Allogeneic Transplantation in AML
  • Allogeneic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia (ALL)
  • Hematopoietic Progenitor Cell Transplantation for Treatment of Chronic Lymphocytic Leukemia
  • The Role of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia Patients in the Era of Tyrosine Kinase Inhibitors
  • Allogeneic Transplantation for Hodgkin’s Lymphoma
  • Myeloablative Allogeneic Stem Cell Transplantation for Non-Hodgkin’s Lymphoma
  • Non-Hodgkin’s Lymphoma: Allogeneic Reduced Intensity Conditioning
  • The Role of Allogeneic Transplantation for Multiple Myeloma in Older Adults
  • Single Versus Tandem Autologous Hematopoietic Stem Cell Transplant in Multiple Myeloma
  • Treatment Strategies for Follicular Center Cell Non-Hodgkin’s Lymphoma
  • The Role of Transplantation in Favorable-Risk Acute Myeloid Leukemia
  • Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukaemia in Adults
  • Allogeneic Transplantation for Myelodysplastic Syndromes
  • Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia
  • Allogeneic Transplantation for the Treatment of Multiple Myeloma
  • Blood Vs. Marrow Allogeneic Stem Cell Transplantation
  • Hematopoietic Cell Transplantation from Partially HLA-Mismatched (HLA-Haploidentical) Related Donors
  • Unrelated Donor Transplants
  • Update on Umbilical Cord Blood Transplantation
  • Selection of Cord Blood Unit(s) for Transplantation
  • Mobilization of Hematopoietic Cells Prior to Autologous or Allogeneic Transplantation
  • Natural Killer-Cell Based Treatment in Hematopoetic Stem Cell Transplantation
  • Cryopreservation of Allogeneic Stem Cell Products
  • Concepts and Controversies in the Use of Novel Preparative Regimens for Allogeneic Stem Cell Transplantation
  • Allogeneic Haematopoietic Stem Cell Transplantation and Natural Killer Cell Alloreactivity
  • Therapeutic Potential of Mesenchymal Stem Cells in Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation for Thalassemia
  • Viral Infections in Hematopoietic Stem Cell Transplant Recipients
  • Fungal Infections
  • Immune Reconstitution and Implications for Immunotherapy Following Hematopoeitic Stem Cell Transplantation
  • Acute Graft Versus Host Disease: Prophylaxis
  • Chronic Graft-Versus-Host Disease
  • Post-transplant Lymphoproliferative Disorder
  • Psychological Care of Adult Allogeneic Transplant Patients
  • Second Allogeneic Transplantation: Outcomes and Indications
  • Minimal Residual Disease
  • Functional Assessment Tools and Co-morbidity Scoring in Hematopoietic Progenitor Cell Transplantation
  • Unique Thrombotic and Hemostatic Complications Associated with Allogeneic Hematopoietic Stem Cell Transplantation
  • How Much Isolation Is Enough for Allografts?
  • Monoclonal Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
  • Treatment of Acute Graft-vs-Host Disease
  • The Importance of Non-Human Primate Models for Pre-clinical Studies in Hematopoiesis
  • In Vivo Models of Allogeneic Hematopoietic Stem Cell Transplantation
  • Dendritic Cells
  • Augmentation of Hematopoietic Stem Cell Transplantation with Anti-cancer Vaccines
  • Erratum To.